Substrate specificity of galactokinase from Streptococcus pneumoniae TIGR4 towards galactose, glucose, and their derivatives
摘要:
Galactokinases (GalKs) have attracted significant research attention for their potential applications in the enzymatic synthesis of unique sugar phosphates. The galactokinase (GalKSpe4) cloned from Streptococcus pneumoniae TIGR4 presents a remarkably broad substrate range including 14 diverse natural and unnatural sugars. TLC and MS studies revealed that GalKSpe4 had relaxed activity towards galactose derivatives with modifications on the C-6, 4- or 2-positions. Additionally, GalKSpe4 can also tolerate glucose while glucose derivatives with modifications on the C-6, 4- or 2-positions were unacceptable. More interestingly, GalKSpe4 can phosphorylate L-mannose in moderate yield (43%), while other L-sugars such as L-Gal cannot be recognized by this enzyme. These results are very significant because there is rarely enzyme reported that can phosphorylate such uncommon substrates as L-mannose. (C) 2012 Elsevier Ltd. All rights reserved.
Catalytic dehydrogenation of reducing sugars in alkaline solution
作者:Gert de Wit、Jan J. de Vlieger、Alida C. Kock-van Dalen、Roelf Heus、Rob Laroy、Antonius J. van Hengstum、Antonius P.G. Kieboom、Herman van Bekkum
DOI:10.1016/s0008-6215(00)86025-5
日期:1981.5
Abstract Aldoses in alkaline medium under the catalytic action of platinum or rhodium are converted into aldonic acids with high selectivity and with concomitant evolution of hydrogen gas. The dehydrogenation reaction has been studied for 25 different mono- and di-saccharides, and is generally applicable for reducingsugars. The influence of several reaction variables has been studied, leading to an
Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo
申请人:ENGENE, INC.
公开号:US10456481B2
公开(公告)日:2019-10-29
Provided herein is chitosan-derivative nanoparticle comprising chitosan functionalized with a cationic amino acid and a hydrophilic polyol; and methods of making and using same, e.g., for gene delivery in vivo.